PATIENTS AT HLTH IMPACT PROGRAM: Will the pace of cancer innovation lead to poorer outcomes?
Dr. Maya Said is the Founder and CEO of Outcomes4Me, a health technology company focused on providing patients diagnosed with cancer and other chronic diseases with personalized treatment options as well as outcomes information. Maya spent the last 20 years working in healthcare, primarily in the pharmaceutical industry with a focus on increasing innovation and access. Despite her extensive experience with healthcare systems globally, it wasn't until she first became a patient herself that she realized much more can be done to improve outcomes and better serve the needs of patients. An engineer and scientist, she strongly believes that technology combined with early patient input can address many of the gaps patients experience today in navigating the healthcare system. Her conviction that technology-based solutions that empower patients can lead to better outcomes led her to create Outcomes4Me.Prior to founding the company, she spent many years as a senior pharmaceutical executive at both Novartis and Sanofi leading global functions including: Market Access, Policy, R&D Strategy, and Business Development. Earlier in her career, Maya was a Partner at the Boston Consulting Group and a founding member of its Strategy Institute.Maya trained at the Massachusetts Institute of Technology (MIT), earning dual degrees in Biology and Electrical Engineering and Computer Science (EECS) with a minor in Economics. She also holds a Master of Science in Toxicology, a Master of Engineering in Electrical Engineering, and Computer Science, and a Doctor of Science in Electrical Engineering, Computer Science, and Systems Biology, all from MIT. She has authored numerous scientific and strategy articles and was honored with the Carlton E. Tucker award for teaching excellence, the Department Head Recognition Award for major contribution to the EECS Department at MIT, and the Burchard Scholar for excellence in humanities and social sciences.
Dr. Maya Said is the Founder and CEO of Outcomes4Me, a health technology company focused on providing patients diagnosed with cancer and other chronic diseases with personalized treatment options as well as outcomes information. Maya spent the last 20 years working in healthcare, primarily in the pharmaceutical industry with a focus on increasing innovation and access. Despite her extensive experience with healthcare systems globally, it wasn't until she first became a patient herself that she realized much more can be done to improve outcomes and better serve the needs of patients. An engineer and scientist, she strongly believes that technology combined with early patient input can address many of the gaps patients experience today in navigating the healthcare system. Her conviction that technology-based solutions that empower patients can lead to better outcomes led her to create Outcomes4Me.Prior to founding the company, she spent many years as a senior pharmaceutical executive at both Novartis and Sanofi leading global functions including: Market Access, Policy, R&D Strategy, and Business Development. Earlier in her career, Maya was a Partner at the Boston Consulting Group and a founding member of its Strategy Institute.Maya trained at the Massachusetts Institute of Technology (MIT), earning dual degrees in Biology and Electrical Engineering and Computer Science (EECS) with a minor in Economics. She also holds a Master of Science in Toxicology, a Master of Engineering in Electrical Engineering, and Computer Science, and a Doctor of Science in Electrical Engineering, Computer Science, and Systems Biology, all from MIT. She has authored numerous scientific and strategy articles and was honored with the Carlton E. Tucker award for teaching excellence, the Department Head Recognition Award for major contribution to the EECS Department at MIT, and the Burchard Scholar for excellence in humanities and social sciences.
Dr. Shikha Jain is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the Division of Hematology and Oncology at the University of Illinois in Chicago. She is the Director of Communications Strategies in Medicine and the Associate Director of Oncology Communication and Digital Innovation for the University of Illinois Cancer Center. Dr. Jain is the Founder and Chair of the Women in Medicine Summit as well as the Founder and President of the 501(c)(3) nonprofit Women in Medicine®. She is also the CEO and Co-Founder of the action, advocacy and amplification 501(c)(3) nonprofit IMPACT and was named one of Medscapes 25 Rising Stars in Medicine in 2020, one of Modern Healthcare's Top 25 Emerging Leaders in 2019 and was also awarded the Rising Star award by LEAD Oncology in 2019. She was appointed by the Science and Technology Directorate of the Department of Homeland Security (DHS S&T) and National Academies of Sciences, Engineering, and Medicine (NASEM) to the Committee on Addressing Inaccurate and Misleading Information on Biological Threats and the Working Group on Engaging the Scientific Community in Countering Scientific Mis- and Disinformation    Dr. Jain is on the Doximity Women in Medicine Advisory Board and is the consulting medical editor for Women in Oncology, on the editorial board of Healio HemOnc Today and the host of the podcast Oncology Overdrive. She was selected as a ResearcHERS ambassador by the American Cancer Society, and was honored by 500 Women in Medicine.  She has been appointed as the 2021 Lead of the American Society for Clinical Oncology Women's Networking Center taskforce, is a member of the Diversity and Inclusion taskforce, and appointed to the Illinois State Medical Society’s Council on Communications and Membership Advocacy as well as the COVID19 taskforce.   Dr. Jain gave a TEDx talk in 2019 on the gender moonshot and the importance of gender parity in healthcare. She is a nationally renowned keynote speaker and writes for several national publications including CNN, USA Today, Scientific American, The Hill, US News and Doximity and has been interviewed in the New York Times and Washington Post.  She is a regular contributor to FOX 32 and has also been a guest on MSNBC, ABC7 and CBS, and other local and national news channels. Dr. Jain has also published extensively in high impact journals such as the New England Journal of Medicine, PNAS, and JAMA.   In her clinical practice as an oncologist she tries to incorporate patient education and outreach as often as possible. With the proper tools and guidance, she works with her patients as a team to treat the disease and helps them move through an often difficult process together with as little stress as possible. She believes in personalized and individualized care, and also feels the more knowledge a patient has about their own disease, the more informed a decision they are able to make. 
Dr. Shikha Jain is a board-certified hematology and oncology physician. She is a tenured associate professor of medicine in the Division of Hematology and Oncology at the University of Illinois in Chicago. She is the Director of Communications Strategies in Medicine and the Associate Director of Oncology Communication and Digital Innovation for the University of Illinois Cancer Center. Dr. Jain is the Founder and Chair of the Women in Medicine Summit as well as the Founder and President of the 501(c)(3) nonprofit Women in Medicine®. She is also the CEO and Co-Founder of the action, advocacy and amplification 501(c)(3) nonprofit IMPACT and was named one of Medscapes 25 Rising Stars in Medicine in 2020, one of Modern Healthcare's Top 25 Emerging Leaders in 2019 and was also awarded the Rising Star award by LEAD Oncology in 2019. She was appointed by the Science and Technology Directorate of the Department of Homeland Security (DHS S&T) and National Academies of Sciences, Engineering, and Medicine (NASEM) to the Committee on Addressing Inaccurate and Misleading Information on Biological Threats and the Working Group on Engaging the Scientific Community in Countering Scientific Mis- and Disinformation    Dr. Jain is on the Doximity Women in Medicine Advisory Board and is the consulting medical editor for Women in Oncology, on the editorial board of Healio HemOnc Today and the host of the podcast Oncology Overdrive. She was selected as a ResearcHERS ambassador by the American Cancer Society, and was honored by 500 Women in Medicine.  She has been appointed as the 2021 Lead of the American Society for Clinical Oncology Women's Networking Center taskforce, is a member of the Diversity and Inclusion taskforce, and appointed to the Illinois State Medical Society’s Council on Communications and Membership Advocacy as well as the COVID19 taskforce.   Dr. Jain gave a TEDx talk in 2019 on the gender moonshot and the importance of gender parity in healthcare. She is a nationally renowned keynote speaker and writes for several national publications including CNN, USA Today, Scientific American, The Hill, US News and Doximity and has been interviewed in the New York Times and Washington Post.  She is a regular contributor to FOX 32 and has also been a guest on MSNBC, ABC7 and CBS, and other local and national news channels. Dr. Jain has also published extensively in high impact journals such as the New England Journal of Medicine, PNAS, and JAMA.   In her clinical practice as an oncologist she tries to incorporate patient education and outreach as often as possible. With the proper tools and guidance, she works with her patients as a team to treat the disease and helps them move through an often difficult process together with as little stress as possible. She believes in personalized and individualized care, and also feels the more knowledge a patient has about their own disease, the more informed a decision they are able to make. 
Abigail Johnston, Esquire is a wife and mother living in Orlando, Florida with her husband and two boys. In 2017, at the age of 38, while tandem breastfeeding her boys, she was diagnosed with de novo Stage IV Metastatic Breast Cancer (MBC). In light of the terminal nature of this diagnosis, Abigail closed her successful law office and now serves as a Patient Advocate between medical appointments, scans and procedures. She volunteers her time with Metavivor, Project Life, FORCE, 305PinkPack and a variety of other organizations focused on the well-being of those living with MBC. Abigail also blogs at NoHalfMeasures.blog about the experiences of living with MBC and addressing the needs of her community.
Abigail Johnston, Esquire is a wife and mother living in Orlando, Florida with her husband and two boys. In 2017, at the age of 38, while tandem breastfeeding her boys, she was diagnosed with de novo Stage IV Metastatic Breast Cancer (MBC). In light of the terminal nature of this diagnosis, Abigail closed her successful law office and now serves as a Patient Advocate between medical appointments, scans and procedures. She volunteers her time with Metavivor, Project Life, FORCE, 305PinkPack and a variety of other organizations focused on the well-being of those living with MBC. Abigail also blogs at NoHalfMeasures.blog about the experiences of living with MBC and addressing the needs of her community.
Kimberly is a survivor of ovarian cancer and early stage, triple positive breast cancer. Her advocacy ranges from serving as pre-Reviewer for DOD, serving on various advisory boards for NQF, NCI, ABEM and ACGME to creating educational content on cancer research and clinical trials. She has established a special commission on Gynecologic Cancer in the state of Illinois, a 2021 recipient of the National Coalition for Cancer Survivorship’s Ellen L. Stovall Award for Patient Innovation in Cancer Care and recently appointed to the PCORI Board of Governors. Kimberly has recently founded the Black Cancer Collaborative, a 501 (c)3 nonprofit organization that creates partnerships between Black cancer patients and the medical and scientific communities on issues of health equity, patient inclusion and clinical trials participation.
Kimberly is a survivor of ovarian cancer and early stage, triple positive breast cancer. Her advocacy ranges from serving as pre-Reviewer for DOD, serving on various advisory boards for NQF, NCI, ABEM and ACGME to creating educational content on cancer research and clinical trials. She has established a special commission on Gynecologic Cancer in the state of Illinois, a 2021 recipient of the National Coalition for Cancer Survivorship’s Ellen L. Stovall Award for Patient Innovation in Cancer Care and recently appointed to the PCORI Board of Governors. Kimberly has recently founded the Black Cancer Collaborative, a 501 (c)3 nonprofit organization that creates partnerships between Black cancer patients and the medical and scientific communities on issues of health equity, patient inclusion and clinical trials participation.